2017 ASCO Annual Meeting
The ASCO Annual Meeting offers informative educational and scientific sessions that highlight the latest in cancer care treatments. The meeting brings together more than 30,000 oncology professionals from around the world to discuss state-of-the-art treatment modalities, new therapies, and ongoing controversies in the field.
XiFin participated by displaying a poster “Challenges of Diagnostic Concordance of Lung Cancer Cases in Qualified Clinical Data Registry (QCDR) Measure Collection by CMS in Calculating MACRA’s Rewards and Penalties.” This poster was sponsored by co-authors Shawn Glisson, MD, Norton Cancer Institute and Timothy Craig Allen, MD, UTMB.
Challenges of Diagnostic Concordance of Lung Cancer Cases in Qualified Clinical Data Registry (QCDR) Measure Collection by CMS in Calculating MACRA’s Rewards and Penalties.
Patricia Goede, Vice President, Clinical Informatics, XiFin Inc.
Poster Presentation
Founded in 1964, the American Society of Clinical Oncology (ASCO) is the world’s leading professional organization for physicians and oncology professionals caring for people with cancer.